News

EMUC17: Using biomarkers in decision-making for RCC treatment

Renal cell carcinomas are among the most lethal in urological malignancies prompting doctors to search for tools such as biomarkers and other molecular techniques to distinguish aggressive diseases. With new research outcomes, physicians are hopeful that diagnosis and therapy...
Oncologist Dr. Andrea Necchi of the Fondazione Irccs Istituto Nazionale Dei Tumori in Milan

EMUC17: Bladder cancer- Challenges in immunotherapy

Immunotherapy is widely anticipated to offer a more prominent role in managing urological cancers but there are unresolved issues and obstacles particularly in the area of managing aggressive bladder cancer, according to experts. “Immunotherapy is likely to play a...
Prof. Anwar Padhani, radiologist, of the Paul Strickland Scanner Centre

EMUC17: Crucial need to standardize MRI use and reporting

There is an urgent need to standardize acquisition, interpretation and reporting of whole body Magnetic Resonance Imaging (MRI) to enable doctors to properly evaluate MRI’s impact on the clinical management of advanced prostate cancer (PCa). “There is a clear...

EMUC17: Examining key topics in urothelial carcinoma

Risk assessment and evaluation of disease extent remain crucial elements in the optimal treatment and management of upper tract urothelial carcinoma, according to experts who emphasise the need for doctors to conduct a better assessment of disease characteristics. “Treatment...

FALCON Workshop focuses on salvage intra-prostatic relapses

The European SocieTy for Radiotherapy & Oncology (ESTRO) organised the educational and multifunctional FALCON (Fellowship in Anatomic delineation and CONtouring) Workshop during the recently concluded 8th European Multidisciplinary Meeting on Urological Cancers (EMUC16). This year’s FALCON Workshop was a...
Tit Albreht: National cancer plans: Key element in cancer prevention

EMUC16: National cancer plans – Key element in cancer prevention

The role of national cancer plans cannot be underestimated and remains a key element for an effective pan-European cancer care programme, according to a public healthcare expert who spoke at the 8th European Multidisciplinary Meeting on Urological Cancers (EMUC16)...
High sensitivity urine biomarkers to detect bladder cancer

EMUC16: High sensitivity urine biomarkers to detect bladder cancer

An investigational, follow-up study by Greek researchers on three urine biomarkers to detect bladder cancer (BCa) has won the first prize for the best unmoderated poster at the recently concluded 8th European Multidisciplinary Meeting on Urological Cancers (EMUC16) held...
http://emuc16.org/wp-content/uploads/KLotz-EMUC16-last-session.jpg

EMUC16: Active Surveillance for early PCa: Impact of new technology

New technology in imaging and genomic investigations have shed insights on disease diagnosis and progression, while at the same challenging standard medical strategies and prompting cancer specialists to re-think treatment approaches. At the concluding session of the 8th European Multidisciplinary...
Impact of sports and lifestyle on uro-oncology

EMUC16: Impact of sports and lifestyle on uro-oncology

Do sports and a healthy lifestyle have a positive impact on health particularly the prostate? This was the central question during the last session of Day 2 at the 8th European Meeting on Urological Cancers (EMUC16) in Milan, Italy....